Investment Rating - The investment rating for the company is "Accumulate" and is maintained [9] Core Views - The company is expected to achieve a net profit attributable to shareholders of 149 million yuan in 2024, representing a year-on-year increase of 89.6%, and a net profit of 61 million yuan in Q1 2025, reflecting a year-on-year growth of 111% [2][6] - Despite the impact of the EU anti-dumping tax, the company is likely to offset risks through overseas channel expansion and new capacity construction, with projects such as the annual production of 100,000 tons of hydrocarbon-based biodiesel and the first phase of 100,000 tons in Singapore expected to enhance profits [2][6] Summary by Sections Financial Performance - In 2024, the company achieved revenue of 3.563 billion yuan, a year-on-year increase of 26.7%, and a net profit of 149 million yuan, a year-on-year increase of 89.6%. The net profit excluding non-recurring items was 135 million yuan, up 24.8% [6] - For Q4 2024, the company reported revenue of 589 million yuan, a year-on-year increase of 115%, and a net profit of 57 million yuan, a year-on-year increase of 176% [6] - In Q1 2025, the company recorded revenue of 709 million yuan, a year-on-year decrease of 18.4%, but a net profit of 61 million yuan, a year-on-year increase of 111% [6] Market Strategy - The company has actively expanded overseas channels and established a self-owned sales network in Europe through its subsidiary in the Netherlands, effectively mitigating the impact of the anti-dumping investigation [13] - The sales model adjustment has allowed the company to recognize revenue at local terminal prices in the EU, resulting in a year-on-year increase of 21.82% in the selling price per ton [13] Profitability Drivers - The profit growth in 2024 was supported by an increase in gross profit per ton, a reduction in expense ratios, and an increase in other income [13] - The gross profit margin for 2024 was 7.11%, a decrease of 0.62 percentage points year-on-year, while the gross profit per ton improved from 482 yuan/ton in 2023 to 524 yuan/ton in 2024 [13] Future Outlook - The company is expected to achieve net profits attributable to shareholders of 410 million yuan, 600 million yuan, and 680 million yuan for 2025, 2026, and 2027, respectively, with corresponding price-to-earnings ratios of 12.9x, 8.7x, and 7.6x [13]

Group 1: Financial Performance - In 2024, the company achieved revenue of 3.563 billion yuan, a year-on-year increase of 26.73%, and a net profit attributable to shareholders of 149 million yuan, a year-on-year increase of 89.57% [1] - For Q1 2025, the company reported revenue of 709 million yuan, a year-on-year decrease of 18.39% but a quarter-on-quarter increase of 20.32%, with a net profit attributable to shareholders of 61 million yuan, a year-on-year increase of 111.22% and a quarter-on-quarter increase of 8.2% [1] - The company plans to distribute a cash dividend of 0.6 million yuan for 2024, accounting for 40.26% of the net profit attributable to shareholders [1] Group 2: Market and Industry Developments - The company has successfully established overseas channels, with significant growth despite the EU's anti-dumping investigations affecting the biodiesel industry [2] - The EU has imposed anti-dumping duties ranging from 10.0% to 35.6% on Chinese biodiesel products, with the company's applicable rate being 23.4% [2] - The company is expanding its international operations, including establishing biodiesel production bases in Singapore and Thailand [2] Group 3: Future Growth Opportunities - The company is poised to benefit from the growing demand for green energy and materials, particularly in the shipping and aviation sectors [3] - The company is advancing projects such as a 100,000-ton hydrocarbon biodiesel production facility and a 50,000-ton natural fatty alcohol project, which are expected to contribute to future revenue [3] - The international maritime organization and various countries have set targets for reducing greenhouse gas emissions, which will drive the demand for biofuels [3] Group 4: Profit Forecast and Investment Outlook - The updated profit forecast for 2025-2027 estimates revenues of 4.582 billion yuan, 6.391 billion yuan, and 7.850 billion yuan, with net profits of 300 million yuan, 533 million yuan, and 706 million yuan respectively [4] - The earnings per share (EPS) are projected to be 2.5 yuan, 4.44 yuan, and 5.88 yuan for the respective years [4] - The investment rating remains "Buy" based on the anticipated release of new production capacity [4]

Investment Rating - The report maintains a "Buy" rating for the company, with a target price not specified [5]. Core Insights - The company reported significant growth in Q1 2025, with revenue of 709 million yuan, a year-on-year decrease of 18.39% but a quarter-on-quarter increase of 20.32%. The net profit attributable to the parent company reached 61 million yuan, marking a year-on-year increase of 111.22% and a quarter-on-quarter increase of 8.2% [1][2]. - The company has successfully expanded its overseas channels, with the Netherlands and Singapore becoming key direct sales platforms. The establishment of a biodiesel production base in Singapore and a new company in Thailand is underway to enhance international operations [2]. - The demand for green energy and materials, particularly in shipping and aviation, is driving the growth of biodiesel derived from waste oils. The company is capitalizing on this trend with new production capacities being released [2][3]. Financial Performance Summary - In 2024, the company achieved a revenue of 3.563 billion yuan, a year-on-year increase of 26.73%, and a net profit of 149 million yuan, up 89.57% year-on-year. The revenue forecast for 2025-2027 is 4.582 billion yuan, 6.391 billion yuan, and 7.850 billion yuan respectively, with net profits projected at 300 million yuan, 532 million yuan, and 706 million yuan [3][4]. - The earnings per share (EPS) are expected to be 2.50 yuan in 2025, 4.44 yuan in 2026, and 5.88 yuan in 2027, indicating strong growth potential [3][4]. - The company’s financial ratios show a projected price-to-earnings (P/E) ratio of 17.38 in 2025, decreasing to 7.40 by 2027, suggesting an attractive valuation as earnings grow [4][11].

Investment Rating - The report maintains a "Buy" rating for the company [2] Core Views - The company has shown significant revenue growth driven by its biodiesel and bio-based products, with a 2024 revenue of 3.563 billion yuan, up 26.73% year-on-year, and a net profit of 149 million yuan, up 89.57% year-on-year [5][9] - The biodiesel segment has seen a sales volume increase of 6.83% and a price increase of 21.82%, contributing to overall revenue growth [6] - The company is expanding its production capacity with new projects, including a 50,000-ton natural fatty alcohol project and a 100,000-ton hydrocarbon-based biodiesel project, which are expected to enhance profitability [7][9] Financial Performance Summary - In 2024, the company achieved a gross margin of 7.11% and a net profit margin of 4.18%, with expectations for significant improvements in the coming years [6][10] - The projected net profits for 2025-2027 are 634 million yuan, 780 million yuan, and 863 million yuan, representing year-on-year growth rates of 325.2%, 23.2%, and 10.6% respectively [9][10] - The company’s earnings per share (EPS) are expected to rise from 1.24 yuan in 2024 to 7.19 yuan by 2027 [10]

Investment Rating - The report maintains a "Buy" rating for the company [2] Core Views - The company has shown significant revenue growth driven by its biodiesel and related products, with a 26.73% year-on-year increase in revenue for 2024, reaching 3.563 billion yuan [5] - The net profit for 2024 increased by 89.57% year-on-year, amounting to 149 million yuan, indicating strong profitability [5] - The company is expanding its production capacity with new projects, including a 50,000-ton natural fatty alcohol project and a 100,000-ton hydrocarbon-based biodiesel project, which are expected to enhance future earnings [7][9] Financial Performance Summary - In 2024, the company reported a total revenue of 3.563 billion yuan, with a net profit of 149 million yuan, and a gross profit margin of 7.1% [8] - The projected revenue for 2025 is 4.783 billion yuan, with net profits expected to rise to 634 million yuan, reflecting a growth rate of 325.2% [9] - The earnings per share (EPS) is forecasted to increase significantly from 1.24 yuan in 2024 to 5.28 yuan in 2025 [10] Market Position and Strategy - The company is leveraging its sales network in Europe and Asia to enhance its market presence, particularly in biodiesel and high-value bio-based materials [6][9] - The strategic focus on cost-effective production through internal sourcing of raw materials is expected to improve profit margins [6][9] - The company is also exploring opportunities in the palm oil and waste oil price differential, which has seen significant increases recently [6]

Revenue and Profit - The company achieved a revenue of 3.563 billion yuan in 2024, representing a year-on-year growth of 26.73% [4] - The net profit attributable to shareholders reached 149 million yuan, a significant increase of 89.57% compared to the previous year [4] - The non-recurring net profit growth was only 24.80%, indicating a heavy reliance on non-operating gains for profit increase [4][6] Global Expansion - The company is actively advancing its global capacity layout, with several new projects making significant progress, including a 50,000-ton natural fatty alcohol project set to start production in April 2025 [5] - The company has established a regional headquarters in Saudi Arabia to manage Middle Eastern cooperation projects and is expanding into high-value applications of biodiesel [5][6] - The company is also focusing on the marine fuel market in non-EU regions, leveraging its presence in Europe and Singapore [5] Research and Innovation - The company increased its R&D expenditure to 120.65 million yuan in 2024, focusing on independent innovation and technical exchanges [6] - Significant breakthroughs were made in areas such as the identification and separation of impurities in low-quality waste oils and the efficient conversion of waste oils [6] - The company obtained 19 authorized patents in 2024, including 4 invention patents, and participated in drafting national standards for bio-based diesel [6]

RSM 容诚 内部控制审计报告 龙岩卓越新能源股份有限公司 容诚审字[2025]361Z0140 号 容诚会计师事务所({ 容诚会计师事务所(特殊普通合伙) 中国 · 北京 您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台（http://acc.bzg.cn）"进行查看 " 章 10 目 1001-1 至 1001-26 (100037) -1 :010-6600 1391 FAX:010-6600 1392 https://www.rsm.global/china/ 内部控制审计报告 容诚审字[2025]361Z0140 号 龙岩卓越新能源股份有限公司全体股东: 按照《企业内部控制审计指引》及中国注册会计师执业准则的相关要求,我 们审计了龙岩卓越新能源股份有限公司(以下简称"卓越新能公司")2024年 12 月 31 日的财务报告内部控制的有效性。 按照《企业内部控制基本规范》、《企业内部控制应用指引》、《企业内部 控制评价指引》的规定,建立健全和有效实施内部控制,并评价其有效性是卓越 新能公司董事会的责任。 二、注册会计师的责任 我们的责任是在实施审计工作的基础上,对财务报告内部控制的有效性发表 ...

RSM | 容诚 审计报告 龙岩卓越新能源股份有限公司 容诚审字|2025|361Z0138 号 容诚会计师事务所(特殊普通合伙) 中国 · 北京 您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台（http://ac.mof.gov.cn）"进行查。 您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台（http://ac.mof.gov.nl）"进行查。 【 目 录 | 序号 | B 容 | 页码 | | --- | --- | --- | | 1 | 审计报告 | I-S | | 2 | 合并资产负债表 | 1 | | 3 | 合并利润表 | 2 | | 4 | 合并现金流量表 | 3 | | 5 | 合并所有者权益变动表 | 4 | | 6 | 母公司资产负债表 | 5 | | 7 | 母公司利润表 | 6 | | 8 | 母公司现金流量表 | 7 | | 9 | 母公司所有者权益变动表 | 8 | | 10 | 财务报表附注 | 9 - 103 | n E : 审计报告 容诚审字[2025]361Z0138 号 龙岩卓越新能源股份有限公司全体股东: 一、审计意见 我们审计了龙岩卓越新能源股 ...

华福证券有限责任公司 关于龙岩卓越新能源股份有限公司 2024 年度募集资金存放与使用情况的 专项核查意见 华福证券有限责任公司(以下简称"华福证券"或"保荐机构")作为承接 龙岩卓越新能源股份有限公司(以下简称"卓越新能"或"公司")首次公开发 行股票持续督导工作的保荐机构,根据《证券发行上市保荐业务管理办法》《上 市公司监管指引第2号 -- 上市公司募集资金管理和使用的监管要求》《上海证 券交易所科创板上市公司自律监管指引第1 号 -- 规范运作》等有关法律法规的 要求,就公司 2024年度募集资金存放与使用情况进行了核查,具体情况如下: 一、募集资金基本情况 (一) 募集资金金额及到位时间 经中国证券监督管理委员会证监许可(2019)1921 号文批准,公司获准向社 会公开发行人民币普通股(A 股)股票 30,000,000 股,每股发行价格为人民币 42.93元,募集资金总额 1.287.900.000.00元,扣除承销及保荐费用、律师费用、 审计及验资费用、用于本次发行的信息披露费用、发行上市手续费及其他费用(不 含增值税）87,003,779.25 元后,公司本次募集资金净额为 1,200,896 ...

龙岩卓越新能源股份有限公司 2024 年度独立董事述职报告 作为龙岩卓越新能源股份有限公司（以下简称"公司"）的独立董事，本人 在报告期内严格依照《公司法》《证券法》《上市公司独立董事管理办法》等法 律法规以及《龙岩卓越新能源股份有限公司章程》（以下简称"《公司章程》"） 的规定，忠实、勤勉、独立地履行职责，认真审议董事会各项议案，现将 2024 年度履职情况向董事会报告如下： 一、独立董事基本情况 （一）个人工作履历、专业背景及兼职情况 作为独立董事，本人均参加了公司召开的董事会和股东大会，在会议前仔细 研究会议资料，主动了解审议事项的相关情况，积极参与各议案的讨论，最大限 度发挥自身专业知识和工作经验优势，提出合理的意见和建议。 2024 年，本人通过现场或通讯方式，出席公司 6 次董事会会议和 2 次股东 大会。本人对任职期内的公司董事会议案均投了同意票。 （二）出席董事会专门委员会会议的情况 本人作为审计委员会成员和召集人，报告期内公司共召开了 4 次审计委员会 会议，本人均按时出席了会议，并充分利用相关专业知识和实践经验，为公司决 策提供了参考依据。 1 郑祯：女，1990 年出生，中国国籍，无境外 ...